Press Esc to close

Welcome to Money Morning - Only the News You Can Profit From.

Close

This Says Our Favorite Biotech Is Off to the Races

Shares of Inovio Pharmaceuticals Inc. (NYSE: INO) – a promising biotech we recommended back in February 2013 – jumped as much as 27% to a three-month high of $14.20 yesterday after the company said a new cancer drug met its main goal in a midstage clinical trial.

Inovio’s shares backtracked a bit as the day progressed but still closed 17.6% higher for the session. Inovio shares have advanced 361% since we first told you about them. The stock has generated a peak gain of 456%, making it one of the 31 recommendations we’ve made to you that have doubled or better since we launched Private Briefing in August 2011. (More on that later…)

Your Advisors

Michael A. Robinson- Money Morning - Only the News You Can Profit From.

Author Image for Michael A. RobinsonMichael A. Robinson
RESEARCH SERVICES

Michael A. Robinson is a 34-year Silicon Valley veteran and one of the top technology financial analysts working today.

His work as a consultant, senior advisor and board member for Silicon Valley venture capital firms has placed him at the center of several major tech innovations including robotics used to revolutionize the auto industry... the $160 billion a year "Cloud Computing" industry... and the latest cyber military technologies.

He's also a Pulitzer Prize-nominated writer and reporter, lauded by the Columbia Journalism Review for his aggressive style. His book "Overdrawn: The Bailout of American Savings" was a prescient look at the anatomy of the nation's S&L crisis, long before the word "bailout" became part of our daily lexicon. It's no wonder that Silicon Valley defense publications vie for Michael's analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.

His status as a leading tech analyst has garnered him rave reviews, too.

As editor of the financial newsletter American Wealth Underground, he amassed an amazing track record. The first analyst to uncover the rare earth mineral crisis, he amassed cumulative gains of 990% for his readers in just 16 months. Today he is the editor of the monthly tech investing newsletter Nova-X Report as well as Radical Technology Profits, where he covers truly radical technologies - ones that have the power to sweep across the globe and change the very fabric of our lives - and profit opportunities they give rise to. He also explores "what's next" in the tech investing world at Strategic Tech Investor.com

Michael has an honors economics degree from the University of Missouri at Columbia. He's also a registered NRA Triple Distinguished Expert in shotgun, pistol, and rifle and one heck of a blues guitarist.